Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion type Assertion NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_head.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion description "[In bladder carcinoma, we recently identified FGFR3 mutations in 41% of tumours, making this the most frequently mutated putative oncogene identified in bladder cancer to date.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_provenance.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion evidence source_evidence_literature NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_provenance.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion SIO_000772 11466624 NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_provenance.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion wasDerivedFrom befree-2016 NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_provenance.
- NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_assertion wasGeneratedBy ECO_0000203 NP324793.RAvCM4zNLJCiVHXcK3qhC305jKoXdLMRSH_gEMR2YGAjY130_provenance.